LENEXA, KS--(Marketwire - December 21, 2009) - XenoTech L.L.C., specialists in evaluation of
drug candidates in vitro, is proud to introduce the latest innovation in
the field of cryopreserved pooled human hepatocytes: CryostaX™.
CryostaX™ is the largest single-freeze pool of cryopreserved human
hepatocytes. This patent-pending single-freeze product offers large lots
of hepatocytes that allow long-term predictable results. Like all of the
XenoTech products, CryostaX™ undergoes a thorough data review to ensure
a dependable, high-quality source of human hepatocytes -- an integral part
of any drug development program.
"CryostaX™ is an example of our continuous commitment to provide the
best products to advance in vitro drug development research," said Andrew
Parkinson, XenoTech's CEO/Chief Scientific Officer.
XenoTech L.L.C. is a Contract Research Organization with years of expertise
in optimizing in vitro test systems and study designs to meet the
ever-changing demands of scientific achievement.
"We're committed to producing high quality scientific tools that provide
great value for pharmaceutical researchers," said Parkinson. "In addition
to quality and value offered today, CryostaX™ allows for future
customization of pooled human hepatocytes for the in-depth pursuit of safe
About XenoTech L.L.C.
XenoTech, founded by Dr. Andrew Parkinson in 1994, is a Contract Research
Organization with unparalleled experience and expertise in evaluating drug
candidates as substrates, inhibitors and inducers of cytochrome P450
enzymes. The Company offers a variety of in vitro contract studies for drug
candidate evaluation, as well as an extensive selection of products for
drug metabolism research. XenoTech's product selection includes a wide
range of high-quality in vitro test systems, from subcellular fractions and
hepatocytes to recombinant enzymes and transporter membranes. The Company
can also prepare and deliver custom-designed products and services in
response to client requests. XenoTech is based in Lenexa, Kansas, U.S.A.
and is a division of Sekisui Medical Company. For additional information,
please email firstname.lastname@example.org or refer to the company's web site at